Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benzodiazepine effect on information processing in generalized anxiety disorder.

Y D Lapierre, H J Butter, L K Oyewumi

    Neuropsychobiology
    |January 1, 1983
    PubMed
    Summary

    Bromazepam treatment significantly reduced electrodermal activity in generalized anxiety disorder patients. Diazepam and placebo showed no significant changes in skin conductance during sensory stimuli presentation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Psychosocial processes influencing weight management among persons newly prescribed atypical antipsychotic medications.

    Journal of psychiatric and mental health nursing·2011
    Same author

    Abnormal involuntary movements: side-effect of neuroleptic drugs.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    Fluphenazine, trifluoperazine and perphenazine in Vacutainers.

    Canadian Medical Association journal·2010
    Same author

    What are the issues surrounding long-term benzodiazepine treatment for generalized anxiety disorder.

    Journal of psychiatry & neuroscience : JPN·2001
    Same author

    Assessing health utilities in schizophrenia. A feasibility study.

    PharmacoEconomics·2000
    Same author

    Olanzapine: safe during clozapine-induced agranulocytosis.

    Journal of clinical psychopharmacology·2000

    Area of Science:

    • Psychopharmacology
    • Neuroscience
    • Clinical Psychology

    Background:

    • Generalized anxiety disorder (GAD) is characterized by heightened physiological arousal.
    • Electrodermal activity (EDA) is a key psychophysiological indicator of arousal.
    • Current treatments for GAD vary in efficacy and side effect profiles.

    Purpose of the Study:

    • To compare the effects of bromazepam, diazepam, and placebo on electrodermal activity in anxious patients.
    • To investigate psychophysiological responses to sensory stimuli under different treatment conditions.
    • To explore the utility of a functional-realistic-instrumental paradigm in anxiety research.

    Main Methods:

    • A double-blind, randomized trial involving 45 adult patients with generalized anxiety disorder.

    Related Experiment Videos

  • Administration of bromazepam, diazepam, or placebo over 14 days.
  • Monitoring of electrodermal activity (skin conductance) in response to non-signal, simple, and complex sensory stimuli at multiple time points.

    • Main Results:

    • Bromazepam treatment led to a significant decrease in skin conductance during visual, auditory, and tactile stimuli.
    • Patients receiving diazepam or placebo did not exhibit significant changes in skin conductance.
    • These findings suggest differential effects of benzodiazepines on psychophysiological arousal in GAD.

    Conclusions:

    • Bromazepam demonstrates potential as a treatment for reducing anxiety-related hyperarousal.
    • Electrodermal activity serves as a sensitive measure for assessing treatment effects in GAD.
    • A functional-realistic-instrumental approach may offer a more comprehensive understanding of anxiety than attentional-arousal models.